ArticleMaterials (Basel, Switzerland)2025
Enhanced Osseointegration, Osteogenic Differentiation and Adherence Behaviour of Healthy Human Osteoblasts on a Roughened Titanium Surface by Vitamin K2 and Vitamin D3.
Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Next-Generation Biomaterials for Hard Tissue Regeneration: Balancing Biofunctionality, Biomimetic Mechanics, and Antimicrobial Resistance.Materials (Basel, Switzerland) · 2026Article
- Enhanced Osteogenic Differentiation of Primary Human Osteoporotic Osteoblasts on a Roughened Titanium Surface by Vitamin K2 and Vitamin D3 Compared to the Differentiation Behaviour of Primary Healthy Human Osteoblasts.Journal of functional biomaterials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The number of endoprosthetic implants is constantly increasing. Successful osseointegration of the inserted material into the bone is essential for a prosthesis to remain in the bone as long as possible. In the clinical setting, a roughened titanium surface of implants is used as standard to enable the best possible osseointegration. Vitamin K2 and vitamin D3 play a decisive role in dynamic bone metabolism and therefore also influence osseointegration. For the first time, we carried out in vitro investigations with clinically relevant cells, primary healthy human osteoblasts (hOBs). We qualitatively compared the adhesion behaviour of hOBs on a plastic surface, a smooth, regular titanium surface structure and a roughened, irregular titanium surface structure by scanning electron microscopy and fluorescence microscopy. The osteogenic behaviour and the osteogenic differentiation capacity were quantitatively investigated by analysing the activity of alkaline phosphatase and the alizarin red S assay under the influence of vitamin K2, vitamin D3 and the combination of both vitamins. It was shown that more adhesion points formed between the cells and the titanium on the rough surface structure. In addition, a solid cell network developed more quickly on this side, with cell runners forming in three-dimensional space, which means the interactions between the cells across different cell layers. On the other hand, a structured cell network also appeared on the regular smooth surface structure, which means that the network seems to be formed and built up along a defined structure. The addition of vitamins further increased the osteogenic differentiation capacity on the rough titanium surface structure. In particular, the isolated addition of vitamin K2 showed an improved osteogenic differentiation in the long-term observation, whereas the combined addition of both vitamins promoted the initial osteogenic differentiation. Vitamin K2, therefore, plays a greater role in osseointegration than previously assumed. This opens up new possibilities for the use of vitamin K2 during and after the surgical insertion of an implant. The use of vitamin K2 should be reconsidered for clinical applications in implant care and further investigated clinically.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.